MGO One Seven LLC Buys 1,845 Shares of Stryker Corporation $SYK

MGO One Seven LLC lifted its stake in Stryker Corporation (NYSE:SYK) by 59.0% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 4,973 shares of the medical technology company’s stock after purchasing an additional 1,845 shares during the period. MGO One Seven LLC’s holdings in Stryker were worth $1,968,000 at the end of the most recent quarter.

Other hedge funds have also recently made changes to their positions in the company. Mar Vista Investment Partners LLC grew its holdings in shares of Stryker by 10.2% in the first quarter. Mar Vista Investment Partners LLC now owns 90,187 shares of the medical technology company’s stock worth $33,572,000 after purchasing an additional 8,353 shares during the last quarter. United Services Automobile Association bought a new position in Stryker during the 1st quarter worth about $2,857,000. AXS Investments LLC grew its holdings in Stryker by 13.7% during the 1st quarter. AXS Investments LLC now owns 8,827 shares of the medical technology company’s stock worth $3,286,000 after acquiring an additional 1,062 shares in the last quarter. Park Edge Advisors LLC bought a new position in Stryker during the 2nd quarter worth about $679,000. Finally, Focus Partners Wealth grew its holdings in Stryker by 1.7% during the 1st quarter. Focus Partners Wealth now owns 130,156 shares of the medical technology company’s stock worth $48,451,000 after acquiring an additional 2,167 shares in the last quarter. 77.09% of the stock is currently owned by institutional investors.

Insider Activity at Stryker

In related news, insider Viju Menon sold 500 shares of the stock in a transaction that occurred on Monday, August 25th. The shares were sold at an average price of $390.61, for a total value of $195,305.00. Following the completion of the transaction, the insider directly owned 12,511 shares of the company’s stock, valued at $4,886,921.71. This trade represents a 3.84% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Ronda E. Stryker sold 200,000 shares of the stock in a transaction that occurred on Wednesday, August 6th. The shares were sold at an average price of $376.45, for a total transaction of $75,290,000.00. Following the completion of the transaction, the director directly owned 3,222,108 shares of the company’s stock, valued at $1,212,962,556.60. The trade was a 5.84% decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 5.20% of the company’s stock.

Stryker Stock Up 1.5%

NYSE:SYK opened at $370.27 on Wednesday. Stryker Corporation has a fifty-two week low of $329.16 and a fifty-two week high of $406.19. The stock has a market capitalization of $141.56 billion, a P/E ratio of 49.04, a P/E/G ratio of 2.63 and a beta of 0.94. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.06 and a current ratio of 1.78. The company’s 50-day simple moving average is $379.71 and its 200-day simple moving average is $378.85.

Stryker (NYSE:SYK) last announced its quarterly earnings data on Thursday, July 31st. The medical technology company reported $3.13 EPS for the quarter, beating the consensus estimate of $3.07 by $0.06. The firm had revenue of $6.02 billion during the quarter, compared to analyst estimates of $5.92 billion. Stryker had a net margin of 12.25% and a return on equity of 23.94%. Stryker’s revenue was up 11.1% on a year-over-year basis. During the same period last year, the firm posted $2.81 EPS. Stryker has set its FY 2025 guidance at 13.400-13.600 EPS. On average, equities analysts anticipate that Stryker Corporation will post 13.47 earnings per share for the current fiscal year.

Stryker Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Tuesday, September 30th will be given a $0.84 dividend. This represents a $3.36 annualized dividend and a dividend yield of 0.9%. The ex-dividend date of this dividend is Tuesday, September 30th. Stryker’s dividend payout ratio (DPR) is presently 44.50%.

Wall Street Analyst Weigh In

SYK has been the topic of several recent research reports. Wall Street Zen cut shares of Stryker from a “buy” rating to a “hold” rating in a report on Friday, September 26th. Redburn Partners set a $420.00 target price on shares of Stryker in a report on Thursday, September 18th. Truist Financial set a $415.00 target price on shares of Stryker and gave the stock a “hold” rating in a report on Monday, August 4th. Wells Fargo & Company increased their target price on shares of Stryker from $435.00 to $445.00 and gave the stock an “overweight” rating in a report on Friday, August 1st. Finally, Needham & Company LLC raised their price target on shares of Stryker from $442.00 to $448.00 and gave the company a “buy” rating in a report on Friday, August 1st. Fifteen equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. Based on data from MarketBeat.com, Stryker currently has a consensus rating of “Moderate Buy” and an average price target of $432.14.

Stryker Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.